Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Deborah Dunsire
Age : 58
Public asset : 3,997,397 USD
Country of residence : Unknown
Linked companies : H. Lundbeck A/S - Ultragenyx Pharmaceutical Inc.

Biography of Deborah Dunsire 
Currently, Deborah L. Dunsire is President & Chief Executive Officer for H. Lundbeck A. She is also Secretary at Biotechnology Innovation Organization and on the board of 6 other companies. In her past career Dr. Dunsire held the position of President, Chief Executive Officer & Director at FORUM Pharmaceuticals, Inc., President, Chief Executive Officer & Director at XTuit Pharmaceuticals, Inc., Vice President-Oncology Business Unit at Novartis AG and Senior Vice President-North America Oncology at Novartis Oncology, Inc. (a subsidiary of Novartis AG) and Director at Takeda Pharmaceutical Co., Ltd. and President, Chief Executive Officer & Director at Millennium Pharmaceuticals, Inc. (a subsidiary of Takeda Pharmaceutical Co., Ltd.). Dr. Dunsire received a graduate degree from the University of the Witwatersrand.


Current positions of Deborah Dunsire 
Holdings of Deborah Dunsire 
Deborah Dunsire : Personal Network 
Most Read News 
07/15JAMIE DIMON : Analysis-JPMorgan hoards cash as Dimon expects rates to rise
RE
07/28MARK ZUCKERBERG : Facebook's slowdown warning hangs over strong ad sales, while Zuckerberg talks 'metaverse'
RE
07/20JEFF BEZOS : billionaire Bezos has successful suborbital jaunt
RE
07/26JEFF BEZOS : Bezos-backed plant food firm NotCo joins unicorn club after latest funding
RE
07/26MICHAEL KLEIN : EV maker Lucid rises in Nasdaq debut after merger with Klein-backed SPAC
RE
07/27RAJESH KUMAR : GE warns of inflationary pressure after lifting cash flow estimate
RE
07/26JEFF BEZOS : Bezos offers NASA $2 billion in exchange for moon mission contract
RE
07/27IAN READ : Exclusive-Rivian ready to invest $5 billion in second U.S. assembly plant -document
RE
07/29TREVOR MILTON : U.S. charges Nikola founder Trevor Milton with lying to investors
RE
07/22RYAN COHEN : Flush from Reddit rally, GameStop plots store revival
RE
More news


© 2021 People and Ownership :   
Deborah Dunsire : Connections 


Latest news about Deborah Dunsire 
2020Activist investor Elliott pushes Alexion Pharma to sell itself
RE
2020Activist investor Elliott pushes Alexion Pharma to sell itself
RE
2020Lundbeck boosted by stockpiling, launches key drug remotely
RE
2020Lundbeck boosted by stockpiling, launches key drug remotely
RE
2020Lundbeck boosted by stockpiling, launches key drug remotely
RE
2019H. Lundbeck A/S completed the acquisition of 63.8% stake in Alder BioPharmaceuticals, Inc. for approximately $970 million.
CI
2019Lundbeck buys Alder in $2 billion migraine treatment move
RE
More news